Published in Am J Kidney Dis on July 01, 2001
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10
Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol (2010) 1.94
Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol (2010) 1.31
Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol (2012) 0.98
Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis (2011) 0.88
Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis. Perit Dial Int (2010) 0.87
Prognostic Value of Residual Urine Volume, GFR by 24-hour Urine Collection, and eGFR in Patients Receiving Dialysis. Clin J Am Soc Nephrol (2017) 0.85
Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis. J Med Life (2015) 0.85
Elderly dialysis patients: analysis of factors affecting long-term survival in 4-year prospective observation. Int Urol Nephrol (2012) 0.84
Comparison of unilateral renal artery embolization versus bilateral for treatment of severe refractory hypertension in hemodialysis patients. World J Urol (2009) 0.82
Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function. Medicine (Baltimore) (2016) 0.80
Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol (2011) 0.80
Arterial Stiffness and Chronic Kidney Disease. Pulse (Basel) (2016) 0.79
The importance of residual renal function in chronic dialysed patients. J Med Life (2010) 0.78
Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: a matched case-control study. Perit Dial Int (2012) 0.78
Low Serum Bicarbonate Predicts Residual Renal Function Loss in Peritoneal Dialysis Patients. Medicine (Baltimore) (2015) 0.78
Residual renal function in hemodialysis patients: the role of Angiotensin-converting enzyme inhibitor in its preservation. ISRN Nephrol (2012) 0.77
Changes in urine volume and serum albumin in incident hemodialysis patients. Hemodial Int (2016) 0.77
Nephrectomy for the failed renal allograft in children: predictors and outcomes. Pediatr Nephrol (2013) 0.77
Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function. Perit Dial Int (2013) 0.77
Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD. Am J Kidney Dis (2016) 0.76
The bacterial colonization in tunneled cuffed dialysis catheter and its effects on residual renal function in incident hemodialysis patients. Clin Exp Nephrol (2015) 0.76
Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients. Medicine (Baltimore) (2015) 0.76
Dialyzer Reuse and Outcomes of High Flux Dialysis. PLoS One (2015) 0.76
Evaluating the benefits of home-based peritoneal dialysis. Int J Nephrol Renovasc Dis (2014) 0.75
Long-term outcomes in children with chronic kidney disease stage 5 over the last 40 years. Arch Med Sci (2017) 0.75
Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy. World J Nephrol (2015) 0.75
Preserving Residual Kidney Function in Hemodialysis Patients-Back in the Spotlight. J Am Soc Nephrol (2016) 0.75
Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection. PLoS One (2015) 0.75
Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function. PLoS One (2014) 0.75
Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization. J Am Soc Nephrol (2015) 0.75
Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease. Kidney Dis (Basel) (2016) 0.75
Sonographic measurement of renal size in patients undergoing chronic hemodialysis: Correlation with residual renal function. Exp Ther Med (2014) 0.75
Does Changing the Volume Matter? The Relationship of Urine Volume and Dialysis Intensity. Clin J Am Soc Nephrol (2016) 0.75
Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial. Clin Exp Nephrol (2016) 0.75
Effect of N-acetylcysteine on residual renal function in chronic haemodialysis patients treated with high-flux synthetic dialysis membranes: a pilot study. ISRN Nephrol (2012) 0.75
Preservation of Residual Kidney Function and Urine Volume in Patients on Dialysis. Clin J Am Soc Nephrol (2017) 0.75
Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol (2017) 0.75
Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination. PLoS One (2017) 0.75
Contrast-induced acute kidney injury: A review of practical points. World J Nephrol (2017) 0.75
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation (1996) 4.62
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation (1999) 2.50
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis (2001) 2.06
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Family history and premature coronary heart disease. J Am Board Fam Pract (1997) 1.45
Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis (2001) 1.43
Hormonal modulation of glomerular function. Am J Physiol (1983) 1.26
Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int (1999) 1.25
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int (2000) 1.19
The kidney and homocysteine metabolism. J Am Soc Nephrol (2001) 1.12
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int (2001) 1.11
Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease. Am J Transplant (2008) 1.07
Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun (1998) 0.99
Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition. Gastroenterology (1976) 0.98
Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation (1994) 0.97
Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transplant (2012) 0.97
Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev (2000) 0.96
Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol (1996) 0.96
Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney Int (2006) 0.95
Sodium balance in renal failure. Curr Opin Nephrol Hypertens (1997) 0.94
Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest (1986) 0.94
Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression. Exp Cell Res (1998) 0.93
Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacity. Clin Nephrol (2006) 0.90
Increase urinary hepatocyte growth factor excretion in human acute renal failure. Clin Nephrol (1997) 0.89
Plasma total homocysteine and hemodialysis access thrombosis: a prospective study. J Am Soc Nephrol (1999) 0.87
Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol (1990) 0.86
Validation of abbreviated oral methionine-loading test. Clin Chem (1995) 0.86
Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy? Am J Kidney Dis (1998) 0.86
Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int (1992) 0.85
Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients? J Am Soc Nephrol (2000) 0.85
Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol (1983) 0.85
In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat. Am J Physiol (1996) 0.84
Na+/H+ exchanger isoform 2 (NHE2) is expressed in the apical membrane of the medullary thick ascending limb. J Membr Biol (1997) 0.84
Homocysteine and arteriosclerosis: subclinical and clinical disease associations. Circulation (1999) 0.84
Does essential hypertension cause end-stage renal disease? Kidney Int Suppl (1992) 0.83
Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr (1996) 0.83
Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol (2001) 0.83
Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat. Am J Physiol Renal Physiol (2000) 0.82
Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy. Kidney Int (1987) 0.81
Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis (1995) 0.80
Glomerular size-selective barrier dysfunction in nephrotoxic serum nephritis. Kidney Int (1988) 0.79
Cryptosporidium infection in renal transplant patients. Clin Nephrol (2005) 0.79
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients. Arterioscler Thromb Vasc Biol (1999) 0.78
Current strategies for management of hypertensive renal disease. Arch Intern Med (1999) 0.78
Renal vascular effects of calcium channel blockers in hypertension. Am J Hypertens (1990) 0.78
Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. J Ren Nutr (2001) 0.78
IgA nephropathy: markers of progression and clues to pathogenesis. Kidney Int (2008) 0.77
Ergometer modification for combined arm-leg use by lower extremity amputees in cardiovascular testing and training. Arch Phys Med Rehabil (1987) 0.77
Treatment of hyperhomocysteinemia in end-stage renal disease. Am J Kidney Dis (2001) 0.77
Renal metabolism of homocysteine in vivo. Biochem Soc Trans (1995) 0.76
Pathogenesis of systemic hypertension and glomerular injury in the spontaneously hypertensive rat. Am J Cardiol (1987) 0.76
Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. J Investig Med (1997) 0.76
Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? Am J Kidney Dis (2000) 0.76
Folic acid fortification of food. JAMA (1996) 0.76
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Kidney Int (2001) 0.76
Abnormalities of lipoprotein metabolism in the nephrotic syndrome. N Engl J Med (1991) 0.75
Effects of fenofibrate and gemfibrozil on plasma homocysteine. Lancet (2001) 0.75
Lipoprotein(a) risk in women and efficacy of ascorbate. JAMA (1994) 0.75
Adjunctive drug therapy for acute myocardial infarction. N Engl J Med (1997) 0.75
Microalbuminuria, lipoproteins, and diabetic control. Ann Intern Med (1993) 0.75
Lipoprotein(a) concentration and risk of atherothrombotic disease. JAMA (1995) 0.75
Methionine loading, vitamin B6 status, and premature thromboembolic disease. Ann Intern Med (1996) 0.75
Serum lipoprotein (a) as a risk factor for extracranial carotid artery atherosclerosis. Mayo Clin Proc (1992) 0.75
Expression of Na+/H+ exchanger isoforms in inner segment of inner medullary collecting duct. J Membr Biol (1998) 0.75
Genomic approaches to elucidating the pathophysiology of renal diseases. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 0.75
Calcium antagonists in the treatment of hypertension: special clinical considerations. Curr Opin Nephrol Hypertens (1996) 0.75
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease. Atherosclerosis (1993) 0.75
Hormonal influences on glomerular function. Contrib Nephrol (1982) 0.75
Clinical outcome in three patients with postpartum hemolytic uremic syndrome treated with frequent plasma exchange. Ther Apher (1998) 0.75
Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients. Transplant Proc (1999) 0.75
Update in nephrology. Med Health R I (1996) 0.75
Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients. J Ren Nutr (2000) 0.75